Carol Glaser received medical treatment from Wound Care Consultants and was later contacted by an attorney who told her that Wound Care might have improperly billed Medicaid for her treatment. She filed this qui tam action under the False Claims Act (“FCA”), 31 U.S.C. § 3730, seeking recovery as a relator foi money the government paid as a result of alleged false or fraudulent Medicare and Medicaid claims submitted by Wound Care. But the government was already aware of the possible improprieties in Wound Care’s billing practices and had commenced an investigation more than four months before Glaser filed her lawsuit. Accordingly, the district court dismissed Glaser’s complaint for lack, of subject-matter jurisdiction under 31 U.S.C. § 3730(e)(4), which blocks jurisdiction if the FCA action is “based upon” a “public disclosure” of the alleged fraudulent conduct “unless ... the person bringing the action is an original source of the information.” Glaser appealed.
The threshold jurisdictional question in this case requires us to determine whether Glaser’s lawsuit is “based upon” a “public disclosure” of Wound Care’s alleged fraudulent billing practices. We. take this opportunity to revisit our prior interpretation of the phrase “based upon” in § 3730(e)(4)(A). In
United States v. Bank of Farmington,
we held that an FCA lawsuit is “based upon” a public disclosure and therefore subject to the jurisdictional bar of § 3730(e)(4) when the lawsuit “depends essentially upon publicly disclosed information and is actually derived from such information.”
We now conclude that the majority interpretation of the phrase “based upon” in the FCA’s jurisdictional bar—which we acknowledged in
Caremark was
supported by “powerful arguments,”
When an FCA relator’s allegations are substantially similar to information about an alleged fraud that is already publicly disclosed, the statute permits the relator to avoid the jurisdictional bar only if he has “direct and independent knowledge of the information on which the allegations are based” and “voluntarily provided the information to the Government before filing” a qui tam action. 31 U.S.C. § 3730(e)(4)(B). Yet under Bank of Farmington’s understanding of when an FCA lawsuit is “based upon” publicly disclosed information, the original-source exception serves no purpose. That is, if the jurisdictional bar kicks in only if the allegations in the relator’s lawsuit are actually derived from a public disclosure, there is no point in asking whether the relator was an original source of the information—he cannot be. Under our present approach, the entire original-source inquiry—asking whether the relator had “direct and independent knowledge” of the information and “voluntarily provided” it to the government—is superfluous. Accordingly, we overrule the interpretation adopted in Bank of Farmington and Caremark and hold that an FCA relator’s complaint is “based upon” publicly disclosed allegations or transactions when the allegations in the relator’s complaint are substantially similar to allegations already in the public domain. 1
Applying this standard to Glaser’s case, we affirm the district court’s application of the jurisdictional bar. Allegations that Wound Care was improperly billing Medicare and Medicaid for services performed by physician’s assistants were publicly disclosed in early 2005 when the government notified Wound Care that it was investigating these billing practices. Glaser’s complaint is based on this publicly disclosed information in that her allegations of fraudulent billing are substantially similar to those the government had already lodged against Wound Care in its investigation. Glaser cannot show she is an original source of the allegations 'in her complaint because she learned about Wound Care’s alleged fraudulent billing from her attorney and then asserted the attorney-client privilege to avoid divulging how her attorney learned of this information. The district court properly dismissed Glaser’s complaint for lack of subject-matter jurisdiction.
*911 I. Background
Both Medicare and Medicaid comprehensively regulate how health-care providers may obtain reimbursement for services provided by physician’s assistants. There are some differences in the regulatory framework for each program, reflecting the fact that Medicare is administered at the federal level by the Department of Health and Human Services and is applied uniformly throughout every state while Medicaid programs are administered at the state level according to rules each state promulgates. We can simplify our analysis in this case by assuming that the general rule under these programs is that physician’s assistants must bill Medicare and Medicaid at a lower rate for the work they do than if the same work had been performed by a doctor. However, a health-care provider may use a doctor’s identification number to bill Medicare and Medicaid for services performed by a physician’s assistant—and thus obtain reimbursement at the doctor’s rate—if the assistant rendered services “incident to” the services of a physician. Most relevant for purposes of this case, an assistant’s services are “incident to” a physician’s services only if the doctor directly supervises the assistant’s performance.
Dr. Steven Miller and Melissa Miller own Wound Care Consultants, which, as its name indicates, provides wound-care services. In January 2005, nearly four months before this lawsuit was filed, a medical-review nurse with the federal Centers for Medicare & Medicaid Services (“CMS”) contacted Wound Care to discuss billing irregularities that had been identified in a routine agency audit. According to a March 2005 letter from CMS, 2 Wound Care allowed an advanced registered nurse practitioner to use Dr. Miller’s identification number to bill Medicare at a higher rate—therefore representing that the nurse practitioner’s services were “incident to” the services of a physician—even though Dr. Miller did not supervise the nurse practitioner’s activity. CMS eventually expanded its audit to review all Medicare claims submitted using Dr. Miller’s identification number. From March 2005 to December 2006, CMS periodically sent letters asking Wound Care to repay funds it received at the higher doctor’s rate rather than at the lower assistant’s rate. Wound Care claims it repaid everything CMS asked it to.
The relator in this case, Carol Glaser, is a Medicaid recipient with post-polio syndrome, respiratory failure, and arthritis. As a result of her conditions, Glaser had numerous wounds that required treatment. Beginning in 2002, Glaser obtained wound-care services from Wound Care on at least 12 occasions, and she says each treatment was provided by a physician’s assistant. Glaser never saw how Wound Care billed Medicaid, and she remained oblivious to Wound Care’s billing practices in general until her attorney in this case, Mary Lapointe, contacted her. 3
*912 We have no idea how Lapointe learned of Wound Care’s billing practices because both Glaser and Lapointe have invoked the attorney-client privilege to avoid revealing Lapointe’s source. We do know that these conversations inspired Glaser to file this suit against Wound Care under the FCA in April 2005. The complaint alleged that Wound Care recorded Glaser’s treatments as having been performed by a physician’s assistant “incident to” Dr. Miller’s services. This practice was fraudulent, Glaser asserted, because Dr. Miller was not on the premises when Glaser received treatment and therefore could not have directly supervised the assistant’s performance.
The government declined to intervene, and Wound Care moved to dismiss Glaser’s suit for lack of subject-matter jurisdiction under 31 U.S.C. § 3730(e)(4) because it was “based upon the public disclosure of allegations or transactions” and Glaser was not an “original source” of CMS’s investigation. Glaser testified that she had no knowledge of Wound Care’s billing practices until Lapointe contacted her, and neither Glaser nor Lapointe have revealed how Lapointe learned of Wound Care’s allegedly fraudulent billing practices. Glaser and Lapointe nevertheless told the district court that they had no knowledge of the CMS investigation when Glaser filed her complaint; in Glaser’s view this was enough to show that her claim was not “based upon” publicly disclosed information because it was not “derived from” the CMS audit.
The district court disagreed and dismissed Glaser’s suit. The court noted that when Glaser filed her suit, CMS had already launched an inquiry into the same billing practices that formed the basis of Glaser’s lawsuit. The district court also concluded that because Glaser testified that all her knowledge of Wound Care’s billing practices came from her attorney and because Glaser refused to say how her attorney learned of the billing irregularities, Glaser had failed to prove that the lawsuit was not “based upon” a public disclosure or that she was an “original source.” The district court denied Glaser’s motion for reconsideration and Glaser appealed.
II. Discussion
We review de novo the district court’s dismissal for lack of subject-matter jurisdiction.
Scott v. Trump Ind., Inc.,
The False Claims Act prohibits the submission of false and fraudulent claims for payment to the government. 31 U.S.C. § 3729(a). It also authorizes private citizens (called “relators”) to file civil actions on behalf of the government (called “qui tam” actions) to recover money that the government paid on account of false or fraudulent claims. Id. § 3730(b)(1). To encourage private citizens to come forward with knowledge of fraudulent activity, the FCA entitles prevailing relators to collect a substantial share of the funds they recover. Id. § 3730(d)(l)-(2). Qui tam actions are subject to a jurisdictional bar when the relator’s action is
based upon the public disclosure of allegations or transactions in a criminal, civil, or administrative hearing, in a congressional, administrative, or Government [sic] Accounting Office report, hearing, audit, or investigation, or from the news media, unless the action is brought by the Attorney General or the *913 person bringing the action is an original source of the information.
Id.
§ 3730(e)(4)(A). As we explained in
United States ex rel. Gear v. Emergency Medical Associates of Illinois, Inc.,
“[t]he bar is designed to deter parasitic
qui tam
actions,”
Under § 3730(e)(4), the district court must conduct a three-step inquiry to determine whether it has jurisdiction to hear a qui tam suit under the False Claims Act. First, it examines whether the relator’s allegations have been “publicly disclosed.” If so, it next asks whether the lawsuit is “based upon” those publicly disclosed allegations. If it is, the court determines whether the relator is an “original source” of the information upon which his lawsuit is based.
See, e.g., Caremark,
A. Have Glaser’s Allegations Been Publicly Disclosed?
For purposes of § 3730(e)(4), a “public disclosure” occurs when “the critical elements exposing the transaction as fraudulent are placed in the public domain.”
United States ex rel. Feingold v. AdminaStar Fed., Inc.,
Glaser contends that the district court erroneously concluded that the CMS investigation into Wound Care’s billing practices constituted a public disclosure, which is a question of law. She believes that unless the allegations of wrongdoing have been widely disseminated, the government must take some affirmative step to publicize its investigation. Nothing in § 3730(e)(4) requires such a showing. To the contrary, we have held that allegations have been publicly disclosed when they appeared in a warning letter from an agency,
United States ex rel. Gross v. AIDS Research Alliance-Chi.,
Here, the allegations against Wound Care were publicly disclosed in an “administrative ... audit or investigation,” 31 U.S.C. § 3730(e)(4)(A), when CMS sent a letter to Dr. Miller in March 2005 demanding repayment for Wound Care’s improper use of Dr. Miller’s billing code. CMS also made clear to Wound Care beginning in January 2005 that it was actively investigating its billing practices. Although Glaser correctly notes that mere governmental awareness of wrongdoing does not mean a public disclosure oc
*914
curred,
see Bank of Farmington,
B. Is the Lawsuit “Based Upon” Publicly Disclosed Information?
To trigger the public-disclosure bar of § 3730(e)(4), it is not enough that allegations of wrongdoing have been publicly disclosed; the relator’s allegations must also be “based upon” the public disclosure. Glaser argues that her allegations are not “based upon” the CMS investigation of Wound Care because they neither depend “essentially upon publicly disclosed information” nor are they “actually derived from such information.”
Caremark,
Glaser’s argument rests on the interpretation of the phrase “based upon” that we adopted in
Bank of Farmington
and reaffirmed in
Caremark.
Those cases held that a qui tam suit is based upon publicly disclosed information when it “depends essentially upon publicly disclosed information and is actually derived from such information.”
Bank of Farmington,
Although the Fourth Circuit has agreed with our approach,
see Siller
Because our approach in
Bank of Farmington
and
Caremark
is out of step with the approach taken by eight other circuits, Wound Care invites us to revisit it. “Although we must give considerable weight to our prior decisions, we are not bound by them absolutely and may overturn Circuit precedent for compelling reasons.”
Russ v. Watts,
We note for starters that only one other circuit (the Fourth) has adopted our interpretation. The Third Circuit has characterized the circuit split as “a clash between two textual arguments ...: one based on the ordinary meaning of the phrase ‘based upon’ and one based on the precept that a statute should be construed if possible so as not to render any of its terms superfluous.”
Mistick,
The original-source exception permits jurisdiction over an FCA action even if the relator’s lawsuit is based upon publicly disclosed information provided that the relator is “an original source of the information.” § 3730(e)(4)(A). The FCA defines an “original source” as someone “who has direct and independent knowledge of the information on which the allegations are based and has voluntarily provided the information to the Government before filing an action under this section which is based on the information.” 31 U.S.C. § 3730(e)(4)(B). If “based upon” means “actually derived from,” as Bank of Farmington says, it is hard to understand the import of the “independent knowledge” component of the original-source exception; a relator who “actually derived” his allegations of fraud from (and therefore “based” his allegations “upon”) information in the public domain could never avoid the jurisdictional bar by showing that he has “independent knowledge” of the fraud. Put another way, following our minority interpretation of “based upon,” once a court concludes that a lawsuit is actually derived from publicly disclosed information, asking the original-source question never affects the jurisdictional result. 5
Conversely, consider what happens when a court following the minority interpretation of “based upon” concludes that a lawsuit is not “actually derived” from publicly disclosed information. In those cases, the court has jurisdiction over the lawsuit whether or not the relator was an original source of the allegations in the qui tarn complaint. Thus, under our minority interpretation of “based upon,” the original-source exception is extraneous no matter how a court resolves the “actually derived from” question. If a court answers the question in the negative, the original-source exception is not implicated; if a court answers in the affirmative, the original-source inquiry is a waste of time.
Despite this difficulty,
Caremark
adhered to the
Bank of Farmington
interpretation—though acknowledging that the circuits in the majority had “powerful arguments” for rejecting it—because “the minority standard holds the trump card, the plain language interpretation.” 496
*917
F.3d at 738. We now conclude that this places too much importance on a dictionary interpretation of the phrase “based upon” to the exclusion of other significant interpretive considerations. Beyond the damage to the originabsource exception, other portions of § 3730(e)(4)(A) would yield baffling results if we read them literally without regard to context. For example, § 3730(e)(4)(A) refers to audits or investigations by the “Government Accounting Office” instead of the General Accounting Office, as well as information obtained from criminal and civil “hearing[s]” even though the statutory bar presumably covers information publicly disclosed in trials, which are not commonly referred to as “hearings.”
See also Mistick,
Ultimately, the interpretation that carried the day in
Bank of Farmington
and
Caremark
violates the principle that “[a] statute should be construed so that effect is given to all its provisions, so that no part will be inoperative or superfluous, void or insignificant”—a principle the Supreme Court recently described as “one of the most basic interpretive canons.”
Corley v. United States,
— U.S. -,
In addition, to be considered an original source, the relator must also have voluntarily disclosed the information to the government before filing a qui tarn action, a requirement that is designed to reward those who come forward with useful information and not those who provide information in response to a governmental inquiry.
See, e.g., United States ex rel. Paranich v. Sorgnard,
To illustrate this, compare our decisions in
Caremark
and
United States ex rel. Lamers v. City of Green Bay,
Caremark justified its continued adherence to the minority approach of Bank of Farmington because it struck a balance between two competing policy concerns: the fear that opportunistic plaintiffs would try to “get in on the action” when they “have nothing new to add”, and the desire to encourage those with knowledge about *919 fraudulent conduct to come forward. Id. These are, as we have noted, the manifest objectives of § 3730(e)(4), but Caremark went astray in thinking that the threshold “based upon” language in the statute addresses these, competing policies by itself. Instead, § 3730(e)(4) must be considered in its entirety.
The threshold jurisdictional bar against lawsuits that are “based upon” publicly disclosed allegations addresses the first policy concern: prohibiting FCA lawsuits filed by opportunistic plaintiffs concerning information about fraud that is already in the public domain. By carving out an exception for original sources, the statute preserves the objective of “inspiring whistleblowers to come forward promptly with information concerning fraud so that the government can stop it and recover ill-gotten gains.”
Findley,
We also note that while the minority interpretation tends to resolve the jurisdictional inquiry at the “based upon” stage, the Supreme Court recently implied in
Rockwell International Corp. v. United States,
The facts of. this case aptly illustrate the flaws in the
Bank of F arming-ton/Caremark
approach. Glaser testified that she learned of Wound Care’s improp
*920
er billing from her attorney, and her attorney said she first became aware of possible fraudulent billing practices in August 2003. That means that more than 20 months elapsed from the time that Glaser’s attorney said she first learned of Wound Care’s, conduct and the time she filed this qui tarn action on Glaser’s behalf. In the meantime, CMS commenced an investigation of Wound Care’s billing irregularities and eventually—some four months
before
Glaser’s lawsuit was filed—notified Wound Care of its findings. The relator provisions of the FCA are designed “to encourage private individuals who are aware of fraud against the government to bring such information forward at the earliest possible time.”
Barth,
Accordingly, we are now convinced that
Bank of Farmington
and
Caremark
gave undue weight to the “dictionary” interpretation of § 3730(e)(4) without considering the phrase “based upon” in the context of the rest of the public-disclosure bar—particularly the original-source exception. Our interpretation of “based upon” as meaning “actually derived from” renders the original-source exception superfluous and ignores the exception’s role in balancing the FCA’s competing policy goals. The majority interpretation, as the Tenth Circuit put it, treats the question of whether a lawsuit is “based upon” a public disclosure as a “threshold analysis ... intended to be a quick trigger for the more exacting original source analysis.”
United States ex rel. Grynberg v. Praxair, Inc.,
Applying this standard to Glaser’s complaint, we conclude that her allegations are based upon the allegations that were the subject of CMS’s prior investigation. As the March 2005 letter from CMS to Dr. Miller makes clear, the CMS investigation focused on whether Wound Care had properly billed the government for services performed by its physician’s assistants. Like the CMS investigation, Glaser’s complaint alleges that Wound Care overbilled the government for physician’s assistants’ services by falsely representing that they had been performed “incident to” a physician’s services. These allegations of wrongdoing are virtually identical—they pertain to the same entity and describe the same fraudulent conduct—which is enough for us to conclude that Glaser’s allegations are substantially similar to the allegations that were at the heart of the CMS investigation.
Glaser argues that her complaint is not based on the CMS investigation because her complaint contains particular allegations of fraud that are not mentioned in CMS’s January or March 2005 communications with Wound Care nor discovered during its investigation into Wound Care’s billing practices. It is true that Glaser’s complaint adds a few allegations not covered by CMS’s investigation. But this is not enough to take this case outside the jurisdictional bar, properly understood; “based upon” does not mean “solely based upon.”
Accord McKenzie,
C. Was Glaser an Original Source of the Allegations in Her Complaint?
Glaser may avoid the public-disclosure bar if she can show that she was an “original source” of the information upon which the allegations in her complaint were based.
See Rockwell,
We question whether Glaser can show she has direct knowledge of the information supporting her allegations. We have never precisely defined the term “direct,” and we need not do so today.
8
But we note that the only knowledge Glaser has of Wound Care’s billing practices comes from her attorney. At oral argument Glaser made much of the fact that she had direct knowledge that she had been treated by a physician’s assistant and not a doctor. But the fraud alleged pertains to the billing, not the treatment. Glaser’s only knowledge that Wound Care’s billing practices were improper came from Lapointe, with whom Glaser had no prior relationship and who contacted her out of the blue. It would be one thing to say that an FCA relator has direct knowledge of the information supporting her allegations because she is personally aware of at least one instance of fraudulent conduct and her attorney’s subsequent investigation uncovers other fraudulent behavior.
See Paranich,
Ultimately, it does not matter whether Glaser could have been deemed to have “direct” knowledge under the statute because she has not met her burden of proving she has “independent” knowledge. To establish this element, we have required that the relator be “someone who would have learned of the allegation or transactions independently of the public disclosure.”
Bank of Farmington,
The problem is that Glaser has asserted the attorney-client privilege to prevent us from learning how her attorney first learned of Wound Care’s billing practices. If a relator says all her knowledge of fraudulent activity comes from a third party (even if the third party is her attorney) but refuses to explain how that third party learned of the fraud, she cannot meet her burden of proving she has independent knowledge just by claiming she had no knowledge of public disclosure. Because Glaser has the burden of proving the jurisdictional facts, she has not established her independent knowledge of improprieties in Wound Care’s billing practices and therefore she cannot be an original source of the allegations in her complaint.
9
See United States ex rel. Houck v. Folding Carton Admin. Comm.,
III. Conclusion
The district court correctly concluded that the jurisdictional bar of § 3730(e)(4)(A) applies to Glaser’s qui tam suit. The allegations in Glaser’s complaint about Wound Care’s billing practices are based upon publicly disclosed information, and Glaser has not shown she is an original source of the information used to support the allegations. We therefore Affirm the judgment of the district court dismissing the case for lack of subject-matter jurisdiction.
Notes
. Because this decision overrules prior decisions of this court, pursuant to Circuit Rule 40(e), we have circulated it among all judges in regular active service. No judge has requested to hear the case en banc. Circuit Judge John Daniel Tinder did not participate in the consideration of this case.
. Technically, the letter was sent by AdminaStar Federal (which has since changed its name to National Government Services). But because AdminaStar contracted with CMS to administer the Medicare program, a responsibility that includes identifying and addressing billing errors, we refer to AdminaStar's investigation as a CMS investigation.
. We do not know when Lapointe first contacted Glaser. Glaser was deposed on June 7, 2007. During her deposition, she testified that she first became aware of potential billing improprieties ‘‘[pjrobably a year and a half ago,” which would be around December 2005. This is almost certainly wrong because her qui tarn action was filed in April 2005 and government officials interviewed Glaser in May 2005. The record is otherwise silent as to when Glaser learned about Wound Care’s improper billing practices from Lapointe.
. The Supreme Court recently granted certiorari to decide the related question of whether a public disclosure has occurred under § 3730(e)(4) when allegations of wrongdoing appear in administrative reports or audits issued by state or local governments, as opposed to the federal government.
See United States ex rel. Wilson v. Graham County Soil & Water Conservation Dist.,
. It is possible to imagine a handful of situations where the original-source exception might have independent meaning, such as if a lawsuit is “actually derived” only in part from public disclosures.
See Mistick,
. Our decision in
Lamers,
which was issued about a month after
Bank of Farmington
was decided, appears to have followed the analysis called for under the majority approach. Since the § 3730(e)(4) inquiry is a sequential one, our consideration of whether the relator was an "original source” necessarily presupposed that the relator’s claim was based on a public disclosure. It is true that
Lamers
did not address how the threshold "based upon” inquiry should be approached. But if
Lamers
had applied the approach we announced in
Bank of Farmington,
our conclusion should have rested on a different ground—namely, that the relator's action was not based upon a public disclosure because the relator did not "actually derive” his allegations from the public disclosure.
E.g., United States ex rel. Cooper v. Blue Cross & Blue Shield of Fla., Inc.,
. We note that the relators in
Caremark
would likely have been able to avoid the jurisdictional bar even under the interpretation of "based upon” that we adopt today because they would have been able to show they were original sources of the information in their complaint. The relators were employed by Caremark at two of its prescription-drug facilities, and they claimed that Caremark engaged in a variety of fraudulent schemes. The allegations against Caremark had been publicly disclosed when Caremark gave the U.S. Attorney’s office thousands of documents during the government's investigation of Caremark’s business practices.
Caremark,
. We note that other courts have used a variety of formulations to describe what Congress meant when it used the term "direct.” Other circuits have interpreted "direct” to mean "marked by absence of an intervening agency, instrumentality, or influence: immediate,”
Stinson,
. It is not necessary to decide in this case whether information obtained by a relator's agent may be imputed to the relator for the purpose of § 3730(e)(4).
